Browse: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | 1 | 3 |
Eli Lilly & Company patentsThe following is a sampling of recent Eli Lilly & Company patent applications (USPTO Patent Application #, Patent Title) sorted by month.
July 2009 - Eli Lilly & Company patents
20090175868 - Igf-ir antagonists as adjuvants for treatment of prostate cancer
20090176863 - Thiophene derivative ppar modulators
20090170913 - Novel mch receptor antagonists
June 2009 - Eli Lilly & Company patents
20090163472 - Mineralocorticoid receptor antagonists and methods of use
20090163472 - Mineralocorticoid receptor antagonists and methods of use
20090163514 - Benzisoxazole piperazine compounds and methods of use thereof
20090163514 - Benzisoxazole piperazine compounds and methods of use thereof
20090163714 - P70 s6 kinase inhibitors
20090163714 - P70 s6 kinase inhibitors
20090155285 - Tgf-beta binding antibodies
20090156547 - Amide prodrug of gemcitabine, compositions and use thereof
20090156571 - Biphenyl amide lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
20090156632 - Dosage regimen for prasugrel
20090156655 - Glucagon receptor antagonists, preparation and therapeutic uses
20090156808 - Processes for the preparation of 3,4-substituted-1,2,5-thiadiazoles and intermediates thereof
20090149445 - Tricyclic steroid hormone nuclear receptor modulators
20090143357 - Heteroaryl urea derivatives useful for inhibiting chk1
May 2009 - Eli Lilly & Company patents
20090136495 - Anti-hepcidin antibodies and uses thereof
20090137632 - Compositions and methods for treating dyslipidemia
20090131638 - Anti-myostatin antibodies
20090118167 - Selective vpac2 receptor peptide agonists
20090118190 - Muteins of fibroblast growth factor 21
20090118254 - Histamine h3 receptor agents, preparation and therapeutic uses
20090118323 - Antitumor benzoylsulfonamides
April 2009 - Eli Lilly & Company patents
20090111742 - Use of fgf-21 and thiazolidinedione for treating type 2 diabetes
20090111800 - Cyclohexylpyrazole-lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
20090111809 - Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
20090105229 - Purine derivatives as kinase inhibitors
20090105229 - Purine derivatives as kinase inhibitors
20090105229 - Purine derivatives as kinase inhibitors
20090105244 - Thienopyridines as allosteric potentiators of the m4 muscarinic receptor
20090105244 - Thienopyridines as allosteric potentiators of the m4 muscarinic receptor
20090105244 - Thienopyridines as allosteric potentiators of the m4 muscarinic receptor
20090099155 - 6-substituted 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists
20090099180 - Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
20090099182 - Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
20090093456 - Novel mch receptor antagonists
20090093524 - Compounds and methods for modulating fxr
20090088428 - Cyclohexylimidiazole lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
20090088428 - Cyclohexylimidiazole lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
20090088430 - Pieridinyl substituted pyrrolidinones as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
20090088430 - Pieridinyl substituted pyrrolidinones as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
March 2009 - Eli Lilly & Company patents
20090082276 - Selective vpac2 receptor peptide agonists
20090074769 - Glp-1 analog fusion proteins
20090069326 - Substituted pyrrolidinones as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
20090069400 - Indole sulfonamide modulators of progesterone receptors
20090060920 - Desacyl ghrelin antibodies and therapeutic uses thereof
20090060924 - Anti-sclerostin antibodies
20090062271 - Antithrombotic diamides
20090062358 - Peroxisome proliferator activated receptor alpha agonists
February 2009 - Eli Lilly & Company patents
20090054444 - Substituted phenylacetamides and their use as glucokinase activators
20090054479 - Fused heterocyclic derivatives as ppar modulators
20090048225 - Histamine h3 receptor agents, preparation and therapeutic uses
January 2009 - Eli Lilly & Company patents
20090023785 - 6-substituted nicotinamide derivatives as opioid receptor antagonists
20090023917 - Selective estrogen receptor modulators for the treatment of vasomotor symptoms
20090018058 - Vitamin d receptor modulators
20090005391 - Tricyclo substituted amides
October 2008 - Eli Lilly & Company patents
20080261875 - Method for treating cardiovascular disease
20080261999 - Azabicycloalkane derivatives useful as nicotinic acetylcholine receptor agonists
20080262004 - Tgf-beta inhibitors
20080255047 - Method of treating acute renal failure with thrombomobulin variant
20080255092 - 6-substituted-2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists
20080255152 - Diaryl ethers as opioid receptor antagonists
September 2008 - Eli Lilly & Company patents
20080234198 - Selective vpac2 receptor peptide agonists
20080234351 - Combination methods for preserving visual acuity
20080227814 - Selective estrogen receptor modulators
20080227839 - Kinase inhibitors
20080221163 - Selective estrogen receptor modulators
20080221217 - Phenyl compounds and their use in the treatment of type ii diabetes
20080213281 - Butyrylcholinesterase variants that alter the activity of chemotherapeutic agents
20080214520 - 6-n-linked heterocycle-substituted 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists
20080214539 - Benzisoxazole piperidine compounds and methods of use thereof
20080214573 - Compounds useful for inhibiting chk1
20080214599 - Use of par-1/par-4 inhibitors for treating or preventing vascular diseases
20080214612 - Selective estrogen receptor modulators containing a phenylsulfonyl group
20080214616 - Pyridine derivatives as dipeptedyl peptidase inhibitors
20080214621 - Cycloalkyl lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
20080215030 - Assembly for filling a container of a delivery device with a pharmaceutical
August 2008 - Eli Lilly & Company patents
20080207588 - Spiro-heterocyclic chromans, thiochromans and dihydroquinolines
20080207685 - Heterocyclic compounds as modulators of peroxisome proliferator activated receptors, useful for the treatment and/or prevention of disorders modulated by a ppar
20080207691 - Cycloalkyl lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
20080207716 - Formulations and dosing regiment for ppar-alpha modulators
20080207732 - Pyrrolidine derivatives as histamine h3 receptor antagonists
20080207735 - 1-amino linked compounds
20080207897 - 6-substituted-2,3,4,5-tetrahydro-1h-benzo[d] azepines as 5-ht2c receptro agonists
20080200507 - Crystalline non-solvated methanesulfonic acid salt of 1-(4-(2-piperidinylethoxy)phenoxy)-2-(3-hydroxyphenyl)-6-hydroxynaphthalene
20080200552 - Vitamin d receptor modulators
20080200555 - Use of norepinephrine reuptake inhibitors for the treatment of tic disorders
20080194482 - Selective apac2 receptor peptide agonists
20080194647 - Pyridyl derivatives and their use as mglu5 antagonists
20080195056 - Apparatus and method for injecting a pharmaceutical
20080188427 - Fish production
July 2008 - Eli Lilly & Company patents
20080182889 - Prodrugs of excitatory amino acids
20080175841 - Antagonistic anti-htnfsf13b human antibodies
20080176864 - Substituted n-arylpyrrolidines as selective androgen receptor modulators
20080176893 - Formulation of a thienopyridine platelet aggregation inhibitor
20080167310 - Modulators of peroxisome proliferator activated receptors (ppar)
June 2008 - Eli Lilly & Company patents
20080153828 - Imidazopyridazine compounds
20080146500 - Selective vpac2 receptor peptide agonists
20080146631 - Oxazolyl-aryloxyacetic acid derivatives and their use as ppar agonists
20080139505 - Potentiators of glutamate receptors
May 2008 - Eli Lilly & Company patents
20080125468 - Glucagon receptor antagonists, preparation and therapeutic uses
20080118498 - Humanized anti-ghrelin antibodies
20080119407 - Vitamin d receptor modulators
20080113905 - Polyethylene glycol linked glp-1 compounds
20080113977 - Mixed lineage kinase modulators
20080113978 - Imidazopyridazine compounds
20080108560 - Heterologous g-csf fusion proteins
20080108594 - Antithrombotic ethers
20080103096 - Muteins of fibroblast growth factor 21
April 2008 - Eli Lilly & Company patents
20080096811 - Selective vpac2 receptor peptide agonists
20080096871 - Olanzapine pamoate dihydrate
20080096923 - Methods for diagnosing and treating diabetic microvascular complications
20080096930 - Potentiators of glutamate receptors
20080089892 - Fc region variants
20080085860 - Selective vpac2 receptor peptide agonists
March 2008 - Eli Lilly & Company patents
20080064742 - Substituted benzopyrans as selective estrogen receptor-beta agonists
20080058385 - A crystalline variable hydrate of (s)-6-(4-(2-((3-9h-carbazol-4-yloxy)-2-hydroxypropyl)amino)-2-methylpropyl)phenoxy)-3-pyridinecarbox amide hemisuccinate salt
February 2008 - Eli Lilly & Company patents
20080050375 - Binding compositions: related reagents
20080051359 - Antisense oligonucleotide modulation of stat3 expression
20080032932 - Method of reducing mortality and morbidity associated with critical illnesses
20080032948 - Novel antifolate combination therapies
January 2008 - Eli Lilly & Company patents
20080026996 - Selective vpac2 receptor reptide agonists
20080027102 - Quinolinyl-pyrrolopyrazoles
20080027397 - Medication dispensing apparatus with triple screw threads for mechanical advantage
20080020387 - Biomarker-optimized adhd treatment
20080015235 - Histamine h3 receptor inhibitors, preparation and therapeutic uses
20080015358 - Fluorination process of protected aminothiazole
20080009433 - Use of glp-1 or analogs in treatment of myocardial infarction
20080004321 - Potentiators of glutamate receptors
20080004330 - Aminomethyl-azacycle derivatives as inhibitors of monoamine uptake
December 2007 - Eli Lilly & Company patents
20070299007 - Muteins of fibroblast growth factor 21
20070299053 - Lactam compound
20070293423 - Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (glp)-1 compound or a melanocortin-4 receptor (mc4) agonist peptide
20070293430 - Muteins of fibroblast growth factor 21
20070287751 - Opioid receptor antagonists
20070281946 - Tri(cyclo) substituted amide compounds
20070281988 - Combination therapy for vascular complications associated with hyperglycemia
November 2007 - Eli Lilly & Company patents
20070270465 - Crystalline 2,5-dione-3-(1-methyl-1h-indol-3-yl)-4-[1-(pyridin-2-ylmethyl) piperidin-4-yl]-1h-indol-3-yl]-1h-pyrrole mono-hydrochloride
20070265200 - Glycol linked fgf-21 compounds
20070265342 - Prodrugs of excitatory amino acids
20070253966 - Fusion proteins
20070254869 - Compounds and methods for treating dislipidemia
October 2007 - Eli Lilly & Company patents
20070249623 - 1-(indole-6-carbonyl-d-phenylglycinyl)-4-(1-methylpiperidin-4-yl)piperazine d-tartrate
20070249677 - Treatment of osteoarthritis and dosing regimen for arzoxifene
20070249688 - Glucagon receptor antagonists, preparation and therapeutic uses
20070244065 - Composition comprising a survivin oligonucleotide and gemcitabine for the treatment of cancer
20070244095 - Compounds and method for treating dyslipidemia
20070237768 - Fgf-21 fusion proteins
20070237775 - Anti-ghrelin antibodies
20070233001 - Injection apparatus having a needle cassette for delivering a pharmaceutical liquid
September 2007 - Eli Lilly & Company patents
20070224188 - Variant fc regions
20070225267 - 3-(2-acylamino-1-hydroxyethyl)-morpholine derivatives and their use as bace inhibitors
20070225372 - Amides as bace inhibitors
20070219507 - Pharmaceutical cartridge piston with rigid core
20070213331 - Pyrrolidine derivatives useful as base inhibitors
20070208003 - Compounds and methods for treating dyslipidemia
20070208024 - Histamine h3 receptor agents, preparation and therapeutic uses
August 2007 - Eli Lilly & Company patents
20070203108 - Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds
20070197604 - Oxazole derivatives as histamine h3 receptor agents,preparation and therapeutic uses
20070197960 - Multiple septum cartridge for medication dispensing device
20070197976 - Medication dispensing apparatus with spring-driven locking feature enabled by administration of final dose
20070190046 - Anti-abeta antibody
20070191784 - Medication dispensing apparatus with gear set having drive member accommodating opening
20070185161 - Bicyclic substituted indole-derivative steroid hormone nuclear receptor modulators
20070178095 - Anti-myostatin antibodies
20070179129 - Opioid receptor antagonists
July 2007 - Eli Lilly & Company patents
20070173452 - Use of glp-1 analogs and derivatives administered peripherally in regulation of obesity
20070173526 - Compounds and methods for treating dyslipidemia
20070167379 - Use of spinosyns for wound healing
20070167636 - Improved process for the asymmetric synthesis of duloxetine
20070161087 - Glp-1 fusion proteins
20070161547 - Modulation of survivin expression
20070161567 - Method of reducing the risk of bone fracture
20070155722 - Fused pyrazole derivatives as tgf-beta signal transduction inhibitors for the treatment of fibrosis and neoplasms
20070155754 - Histamine h3 receptor antagonists, preparation and therapeutic uses
20070155793 - 4-(5-aminomethyl)-indole-1-ylmethyl)-benzamide derivatives and related compounds as opioid receptor antagonists for the treatment of obesity
June 2007 - Eli Lilly & Company patents
20070149810 - Vitamin d receptor modulators
20070141052 - Fc region variants
20070142278 - Muteins of fibroblast growth factor 21
20070142293 - Methods of treating diseases with activated protein c
20070142441 - Ampa receptor potentiators
20070142789 - Medication dispensing apparatus configured for rotate to prime and pull/push to inject functionality
20070135484 - Benzenesulfonic acid indol-5-yl esters as antagonists of the 5-ht6 receptor
20070135485 - Novel mch receptor antagonists
May 2007 - Eli Lilly & Company patents
20070123453 - Uses of melanocortin-4 receptor (mc4r) agonist peptides administered by continuous infusion
20070111988 - Selective estrogen receptor modulators
20070112036 - Opioid receptor antagonists
20070112045 - Triazole ppar modulators
20070105759 - Melanocortin receptor 4 (mc4) agonists and their uses
20070105845 - Quinolone derivatives
20070105852 - Thiophene and furan compounds
20070105951 - Phenyl-furan compounds as vitamin d receptor modulators
20070105960 - Treatment of learning disabilities and motor skills disorder with norepinephrine reuptake inhibitors
20070106081 - Bicyclic derivatives as ppar modulators
20070106082 - Substituted benzopyrans as selective estrogen receptor-beta agonists
20070106095 - Vitamin d receptor modulators
20070099909 - N-(2-arylethyl)benzylamines as antagonists of the 5-ht6 receptor
20070100133 - Erythropoietic compounds
April 2007 - Eli Lilly & Company patents
20070093526 - 4-amino-piperidine derivatives as monoamine uptake inhibitors
20070088016 - Tricyclic steroid hormone nuclear receptor modulators
20070088018 - Cb1 antagonist compounds
20070088288 - Fixed dose medication dispensing device
20070082907 - Peroxisome proliferator activated receptor modulators
20070083046 - Morpholine derivatives as norepinephrine reuptake inhibitors
20070078166 - Novel crystalline forms of {2-[1-(3,5-bis-trifluoromethyl-benzyl)-5-pyridin-4-yl-1h-[1,2,3] triazol-4-yl]-pyridin-3-yl}-(2-chlorophenyl)-methanone
20070078169 - Substituted (4-aminocyclohexen-1-yl)phenyl and (4-aminocyclohexen-1-yl)pyridinyl compounds as 5-ht1f agonists
February 2007 - Eli Lilly & Company patents
20070041986 - Synthetic polysaccharide antigens for immunological intervention in disease
20070042022 - Liquid formulations of ractopamine
20070043040 - Inhibitors of akt (protein kinase b)
20070043220 - Pyrazole derivative as ppar modulator
20070036761 - Lentiviral apoe2 gene therapy
20070036806 - Glp-1 analog fusion proteins
20070037788 - Tricyclic steroid hormone nuclear receptor modulators
20070037796 - 7-phenyl-isoquinoline-5-sulfonylamino derivatives as inhibitors of akt (proteinkinase b)
20070037812 - Phenoxyether derivatives as ppar modulators
20070032554 - Treatment of stuttering and other communication disorders with norepinephrine reuptake inhibitors
20070027185 - Antithrombotic aromatic ethers
January 2007 - Eli Lilly & Company patents
20070021343 - Stabilized teriparatide solutions
20070021344 - Stabilized teriparatide solutions
20070015786 - Treatment of hot flashes, impulse control disorders and personality change due to a general medical condition
20070010558 - Opioid receptor antagonists
December 2006 - Eli Lilly & Company patents
20060293223 - Uses of melanocortin-3 receptor (mc3r) agonist peptides
20060293385 - Vitamin d receptor modulators
20060287536 - Phenyl-thiophene type vitamin d receptor modulators
20060281787 - Bisindolyl maleimides useful for treating prostate cancer and akt-mediated diseases
20060276522 - Benzisothiazol-3-one-carboxylic acid amides as phospholipase inhibitors
20060276532 - Ampa receptor potentiators
November 2006 - Eli Lilly & Company patents
20060269549 - Tnf-alpha binding molecules
20060269550 - Anti-ghrelin fab antibodies
20060270656 - Substituted piperazines of azepines, oxazepines and thiazepines
20060270713 - 3-aminopyrrolidines as inhibitors of monoamine uptake
20060263345 - Butyrylcholinesterase variant polypeptides with increased catalytic efficiency and methods of use
20060263849 - Glucagon-like peptide-1 analogs
20060264418 - 6-(2,2,2-trifluoroethylamino-7-chloro-2,3,4,5-tetrahydro-1h-benzo[d] azephine as a 5-ht2c receptor agonist
20060257973 - Pseudomycin production by pseudomonas syringae
20060257987 - Ppar modulators
20060258654 - Pyridinylmorpholine derivatives
20060251652 - Cd20 binding molecules
20060252693 - Glucagon-like peptide-1 analogs
20060252916 - Modified glucagon-like peptide-1 analogs
October 2006 - Eli Lilly & Company patents
20060241157 - Heterocyclic ppar modulators
20060241188 - Treatment of pervasive developemental disorders with norepinephrine reuptake inhibitors
20060233788 - Anti-ghrelin antibodies
20060235222 - Indole-derivative modulators of steroid hormone nuclear receptors
20060228366 - Tumor specific monoclonal antibodies
20060223871 - Thiophene-and thiazolesulfonamides as antineoplastic agents
September 2006 - Eli Lilly & Company patents
20060217290 - Insulin analogs having protracted time action
20060217339 - Antisense oligonucleotide modulation of stat3 expression
20060217351 - Method for treating cardiovascular diseases
20060217372 - Diaryl ethers as opioid receptor antagonist
20060217433 - Sulfonamide derivatives as ppar modulators
20060211734 - (piperidinyloxy)phenyl, (piperidinyloxy)pyridinyl, (piperidinylsulfanyl)phenyl and (piperidinylsulfanyl)pyridinyl compounds as 5-ht1f agonists
20060204489 - Protein c derivatives
20060205041 - Recombinant bovine thrombin
20060205715 - 6-substituted nicotinamide derivatives as opioid receptor antagonists
20060205744 - Fused heterocyclic derivatives as ppar modulators
20060206057 - Medication dispensing apparatus with triple screw threads for mechanical advantage
20060199858 - Substituted benzopyrans as selective estrogen receptor-beta agonists
###
This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Eli Lilly & Company in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Eli Lilly & Company with additional patents listed. Browse our Agent directory for other possible listings.
###
FreshPatents.com Support
|
REGISTER now for FREE 
